GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Novelix Pharmaceuticals Ltd (BOM:536565) » Definitions » PB Ratio

Novelix Pharmaceuticals (BOM:536565) PB Ratio : 2.68 (As of Jan. 18, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Novelix Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-01-18), Novelix Pharmaceuticals's share price is ₹24.15. Novelix Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2024 was ₹9.03. Hence, Novelix Pharmaceuticals's PB Ratio of today is 2.68.

The historical rank and industry rank for Novelix Pharmaceuticals's PB Ratio or its related term are showing as below:

BOM:536565' s PB Ratio Range Over the Past 10 Years
Min: 0.14   Med: 0.62   Max: 2.68
Current: 2.68

During the past 13 years, Novelix Pharmaceuticals's highest PB Ratio was 2.68. The lowest was 0.14. And the median was 0.62.

BOM:536565's PB Ratio is ranked worse than
78.22% of 101 companies
in the Medical Distribution industry
Industry Median: 1.28 vs BOM:536565: 2.68

During the past 12 months, Novelix Pharmaceuticals's average Book Value Per Share Growth Rate was 3.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 2.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -8.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -5.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Novelix Pharmaceuticals was 129.30% per year. The lowest was -15.00% per year. And the median was 0.20% per year.

Back to Basics: PB Ratio


Novelix Pharmaceuticals PB Ratio Historical Data

The historical data trend for Novelix Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novelix Pharmaceuticals PB Ratio Chart

Novelix Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.80 0.99 1.01 1.89

Novelix Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 - 1.89 - 2.43

Competitive Comparison of Novelix Pharmaceuticals's PB Ratio

For the Medical Distribution subindustry, Novelix Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novelix Pharmaceuticals's PB Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Novelix Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Novelix Pharmaceuticals's PB Ratio falls into.



Novelix Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Novelix Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=24.15/9.026
=2.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Novelix Pharmaceuticals  (BOM:536565) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Novelix Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Novelix Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novelix Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Chirag Ali Lane, 5-8-354/1106, office No. 1106, Ratna Block, Raghav Ratna towers, Abids, Hyderabad, TG, IND, 500001
Novelix Pharmaceuticals Ltd formerly Trimurthi Ltd is an India based pharmaceutical supplier. It operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. It operates through the following business segments: Pharma Business, Financial Activity, Investment Activity, Foods, and Trading in Shares. Its products include medicine for contraception, obstetrics and gynecology, digestive system, and other areas.

Novelix Pharmaceuticals Headlines

No Headlines